23 September 2026
ASMED® at the 24th SEMAL Congress in Madrid, 1-3 October 2026
From 1 to 3 October, ASMED® is exhibiting at the 24th SEMAL congress on anti-ageing and longevity medicine in Madrid: Sala Liria, stand no. 12.
For doctors, dentists and psychologists
REAC® Technology: expanding the possibilities of the therapeutic pathway.
How often do you follow patients in whom pain, postural or motor changes, anxiety or stress persist despite the set path?
Neurobiological modulation based on REAC® Technology combines treatments already in use with a non-invasive, painless and drug-free option: standardized protocols, sessions of a few minutes, no changes to the outpatient activity. ASMED® has been producing it since 2002 and accompanies the professional from evaluation to daily use.
- Without medication
Non-invasive and painless, alongside ongoing therapies.
- Credibility
REAC® Technology studies indexed on PubMed.
- Easy to apply
Standardized protocols, sessions of a few minutes.
- Support to the professional
Training, support and assistance at every stage.
- Research and development
Continuous research activity since 2002.
- Safety and reliability
ISO 13485:2016 certified quality system, CE devices.
Where REAC® may have relevance in your practice
Four frequent clinical situations in which the usual path leaves a margin. For each: what exists, what has been studied, with what limits.
Disorders of mood and behavior
Find out more →
Postural and motor disorders
Find out more →
Pain syndromes
Find out more →
Reparative and regenerative processes
Find out more →
The indications for use, contraindications and warnings are those contained in the technical documentation and in the instructions for use of the device.
Certified quality.
Documentation available for consultation.
ASMED® quality management system is certified according to the international standard ISO 13485:2016. Certificates and device records are published and available for consultation.
-
ISO 13485:2016 certified quality management system
-
Device with CE marking and declaration of conformity
-
ANVISA registration and INMETRO certification for Brazil
-
Comprehensive and up-to-date clinical and technical documentation
And then what? From evaluation to daily use.
No changes to the organisation of your practice: a single point of contact, start-up training, support during the first applications, ongoing assistance.
Discover the pathway →Initial assessment
Presentation of technology and analysis of protocol integration in clinical practice.
Training
Training in the use of the device and protocols, with dedicated material and documentation.
Supported start
Initiation of clinical use with support in the first applications of the protocols.
Ongoing assistance
Technical assistance and scientific support, updates and maintenance.
News and updates
Go to news →
23 September 2026
4 June 2026
The efficacy of REAC® Technology in managing depression, anxiety and stress: evidence from the DASS-42 study
REAC-NPO and REAC-NPPO neurobiological modulation treatments in the management of anxiety, depression and stress.
11 May 2026
REAC® Technology and Alzheimer’s disease: a controlled clinical trial on motor effects
A randomized cross-over study evaluates the feasibility, safety and motor effects of the REAC® NPO protocol in 60 patients.
7 March 2026
Clinical performance of REAC biomodulation in the treatment of low-grade inflammation
Analysis of the clinical results of the PMCF study on the REAC ACT, CO and MO-IBZ protocols.
Are you a patient or a caregiver?
This site is aimed at professional operators. For information on treatments you can contact the Rinaldi Fontani Institute in Florence.
